The findings provide insight into which patients may have favorable or inferior responses to immunotherapy for small cell ...

A federal judge is considering the 47th presidential administration’s request to unseal FBI surveillance records on Martin Luther King Jr.—currently sealed until 2027—amid opposition from King’s ...

While the approval is a historic event for the BiTE drug class in solid tumours, the market share opportunity is restricted ...

For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...

(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced positive results from the Phase III IMforte study of Tecentriq (atezolizumab) in combination with lurbinectedin (Zepzelca) as a fi ...

Eared Books. How did a white guy from Iowa decide to write a book about a crucial period in the civil rights ...

Here’s your chance to join the Tuscaloosa County Chapter of the Southern Christian Leadership Conference (SCLC) during the ...

The field of Cancer Immunity & Immunotherapy is entering an exciting new phase. While Volume I (see here) of this Research Topic highlighted broad ...

Tarlatamab prolonged both overall and progression-free survival in the treatment of small cell lung cancer, backing it as a ...

The coveted designation for GSK5764227 (GSK'227, previously known as HS-20093) is for the use of the ADC to treat relapsed or refractory extensive-stage small-cell lung cancer (SCLC) and comes ...